Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 123441-03-2 | Product Number: R0250
Rivastigmine
Purity: >98.0%(HPLC)
- (S)-3-[1-(Dimethylamino)ethyl]phenyl Ethyl(methyl)carbamate
- Ethylmethylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | R0250 |
Purity / Analysis Method
|
>98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__4H__2__2N__2O__2 = 250.34 |
| Physical State (20 deg.C) | Liquid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| CAS RN | 123441-03-2 |
| Reaxys Registry Number | 7875788 |
| PubChem Substance ID | 468592798 |
| MDL Number | MFCD00871496 |
| Appearance | Colorless to Light yellow clear liquid |
| Purity(HPLC) | min. 98.0 area% |
| Specific rotation | -31.0 to -35.0deg (C=1, ethanol) |
| NMR | confirm to structure |
| Boiling Point | 135 °C/0.26 mmHg |
| Flash point | 145.0 °C |
| Specific Gravity (20/20) | 1.03 |
| Solubility in water | Slightly soluble |
| Solubility (miscible with) | Methanol, Ethanol |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
| RTECS# | FA9546000 |
| UN Number | UN2810 |
| Class | 6.1 |
| Packing Group | III |
| HS Number | 2924297099 |
References
- Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro
- Kinetic and Structural Studies on the Interaction of Cholinesterases with the Anti-Alzheimer Drug Rivastigmine
- Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors
- A review of rivastigmine: a reversible cholinesterase inhibitor
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.